Skip to main content
. Author manuscript; available in PMC: 2018 Dec 12.
Published in final edited form as: Mol Psychiatry. 2018 Jun 12:10.1038/s41380-018-0103-8. doi: 10.1038/s41380-018-0103-8

Table 1.

summary of the molecular findings and the clinical presentation of the ATP1A3 mutation carriers

Case 1 Case 2 NSB1251
Mutation in ATP1A3 gene NM_152296.4(ATP1A3):c.2401G>A (p.Asp801Asn) NM_152296.4(ATP1A3):c.2443G>A (p.Glu815Lys) NM_152296.4(ATP1A3):c.2438C>T (p.Ala813Val)
Pathogenicity Reported in ClinVar (ID:37108) Reported in ClinVar (ID:37107) Not reported, predicted damaging
Inheritance De novo De novo Inherited from the mother
Age of onset for psychiatric symptoms 10 12 10
Sex Male Male Male
Main psychiatric symptoms Fluctuant visual and auditory hallucinations, delusions of persecution, psychomotor agitation and aggressiveness Visual hallucinations (distortion of lights and shadows) followed by auditory and tactile hallucinations, delusion with persecutory and mystic ideas
Negative symptoms with major social withdrawal
Positive symptoms: delusions and hallucinations
Dysmorphic features Short philtrum, large ears with low implantation, gum hypertrophy, exotropia and macrocephaly Macroglossy, nystagmus, esotropia and short philtrum and cleft palate ?
Neurodevelopmental delays Moderate intellectual disability, developmental delays, reading and writing skills are not acquired Walk at 25 months, first word around 4 years old, severe hypotonia Intellectual disability with verbal intelligence quotient (IQ) of 75 and performance IQ of 57
Response to treatment Poor Poor ?
Associated phenotype Recurrent major depressive disorder Autism Spectrum Disorder Autism Spectrum Disorder